Trusted by many for our results-driven track record
Let the facts do the talking.
1600+ global
clinical trials
16+ years of
industry experience
Proprietary technology
supported by published
research
DMC-HUB
Empowering technology with an independent working environment and centralized management for the entire IDMC process.
eBinder™
Improve the efficiency of your clinical trials and eliminate the need for manual data entry by automatically uploading patient information into a secure database with eBinder™. Integrate eBinder™ into the EDC and Source Data Capture (SDC) systems or used as a standalone tool.
Innovative Solutions
With our suite of Innovative Solutions, we’re constantly pushing the boundaries of what’s possible. From providing insights that predict the outcome of trials to automating the site data capture process, we stand by our motto of reshaping the future of clinical trials.
eClinical Solutions
Our EDC and IWRS are integrated with the CIMS DDM™ to create a closed system that runs complex statistical and mathematical computations and simulations.
How our innovative solutions clinical trial package impacts drug development
With the CIMS closed system, we can determine if your drug is working or failing in nearly half the time of the current standard.
Trial optimization
Optimize your on-going trial to maximize its success.
Early termination of hopeless trials
Receive alerts to conduct a formal futility analysis, enrich your population, or modify your sample size.
Drug safety detection
Continue monitoring drug safety and signal detection.
Dose selection
Optimize a Phase 2/3 combination trial by identifying potential doses for Phase 3.
Population selection
Intelligently identify the most effective subpopulation. Apply to an RCT or RWE setting for personalized medicine.
Sample size re-estimation
Intelligently estimate an optimal sample size to maximize the probability of success.
Model checking and correction
Check and verify the assumptions set prior to the initiation of the trial.
“We’re implementing Dynamic Trial Design in our upcoming study and expect it to reduce our trial costs by a significant amount.”
Bob Smith
VP of Clinical Development, DS Biopharma
Let’s transform the clinical trial experience together
Contact CIMS today to speak to a representative and learn how we can revolutionize your clinical trials.